BioTek Instruments has appointed Millennium Science as their official distributor in New Zealand. Millennium Science will now be responsible for sales and support of the company?s entire line of microplate-based instrumentation and software in New Zealand and Australia.
BioTek Instruments has appointed Millennium Science as their official distributor in New Zealand. Millennium Science will now be responsible for sales and support of the company’s entire line of microplate-based instrumentation and software in New Zealand and Australia.
"Our long-standing relationship with BioTek in Australia, together with our proven experience in laboratory automation, puts us in an excellent position to serve the needs of New Zealand life science researchers", said Bren Collinson, managing director at Millennium Science in a statement. "We are very pleased to now be the exclusive distributor in New Zealand for the entire BioTek product line."
"Millennium has a strong focus on applications with expert technical sales and support. They are a natural fit for BioTek as we grow in Australasia," added Dominic Herring, business development manager of BioTek Instruments Singapore.
According to the company, BioTek instrumentation is used to facilitate the drug discovery process, to advance discoveries in genomics and proteomics and to aid in the advancement of life science research.
For more information about BioTek visit www.biotek.com
More on Millennium Science is available at www.mscience.com.au
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.